H.R. 8024: Maternal Vaccination Act

This bill, known as the Maternal Vaccination Act, proposes several amendments to the Public Health Service Act to enhance awareness and equity in maternal vaccination. The key provisions include:

Awareness Campaign

The bill seeks to broaden the existing maternal vaccination awareness campaign, specifically targeting pregnant and postpartum individuals. This includes:

• Including "pregnant and postpartum individuals" specifically in discussions about low vaccination rates.
• Expanding the focus from prenatal and pediatric care to include prenatal, obstetric, and pediatric care.
• Ensuring that the campaign addresses the needs of pregnant and postpartum individuals, in addition to other groups.
• Increasing the funding for this campaign from $15 million (for fiscal years 2021 to 2025) to $17 million annually (for fiscal years 2027 to 2031).

Additional Activities

The bill also aims to enhance additional activities related to maternal vaccination by:

• Including efforts to increase vaccination rates among pregnant and postpartum individuals, particularly focusing on racial and ethnic minority groups.
• Adjusting language in the Public Health Service Act to reflect these broader goals, ensuring the inclusion of new targeted populations.

Overall, the Maternal Vaccination Act intends to strengthen maternal vaccination efforts, with an emphasis on increasing awareness and accessibility, particularly for underrepresented groups and individuals during and after pregnancy.

Relevant Companies

• PFE - Pfizer Inc.: Pfizer is involved in producing vaccines, and an increase in maternal vaccination initiatives could impact their vaccine distribution and marketing strategies.
• MRK - Merck & Co., Inc.: Merck also develops vaccines, and the increased focus on maternal vaccination may drive demand for their products aimed at this demographic.